Isavuconazole safe and effective to treat aspergillus infection in patients with cancer

Share this content:

the ONA take:

According to new research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2014), isavuconazole is as effective as voriconazole for the treatment of aspergillus infection in patients with cancer. In the phase 3 study comparing isavuconazole, new antifungal agent, with voriconazole in patients with uncontrolled cancer, researchers found that the two agents were equally efficacious against the invasive fungal disease.


Furthermore, researchers observed fewer adverse effects associated with isavuconazole versus voriconazole. Compared with those that took voriconzaole, patients who took isavuconazole had less ocular, epidermal, and hepatobiliary toxicity.


Fungal infections caused by aspergillus and other fungi can be particularly harmful in immunocompromised patients undergoing treatment for cancer. These fungal infections often increase morbidity and mortality in these patients, especially those with hematological malignancies like leukemia and lymphoma.


Based on the results of the study, Astellas and Basilea Pharmaceutica International Ltd. have submitted a new drug application to the U.S. Food and Drug Administration (FDA) for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis.

Chemotherapy drug shortages common to oncologists
Isavuconazole as effective as voriconazole for treatment of aspergillus infection in patients with cancer.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
READ FULL ARTICLE From Medical News Today
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs